Home/AudioCure Pharma/Dr. Reimar Schlingensiepen, MD
DR

Dr. Reimar Schlingensiepen, MD

Chief Executive Officer

AudioCure Pharma

Therapeutic Areas

AudioCure Pharma Pipeline

DrugIndicationPhase
AC102Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)Phase 2